RT Journal Article
SR Electronic
T1 1-C Nonlinear Covid-19 Epidemic Model and Application to the Epidemic Prediction in France
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.24.20111807
DO 10.1101/2020.05.24.20111807
A1 Quadrat, J.-P.
YR 2020
UL http://medrxiv.org/content/early/2020/05/26/2020.05.24.20111807.abstract
AB We have shown in a previous paper that the standard time-invariant SIR model was not effective to predict the 2019-20 coronavirus pandemic propagation. We have proposed a new model predicting z the logarithm of the number of detected-contaminated people. It follows a linear dynamical system ż = b − az. We show here that we can improve this prediction using a non linear model ż = b − azr where r is an exponent that we have also to estimate from data. Some countries have an epidemic with a bell shaped form that we call unimodal epidemic. With this new model, we fit observed data of different countries having an unimodal epidemic with a surprising quality. We discuss also the prediction quality obtained with these models at the epidemic start in France. Finally, we evaluate the containment impact on the Covid French mortality in hospitals.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNoAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NoAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWikipedia